BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21980113)

  • 1. Balancing calcium signals through TRPC5 and TRPC6 in podocytes.
    Greka A; Mundel P
    J Am Soc Nephrol; 2011 Nov; 22(11):1969-80. PubMed ID: 21980113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.
    Hall G; Rowell J; Farinelli F; Gbadegesin RA; Lavin P; Wu G; Homstad A; Malone A; Lindsey T; Jiang R; Spurney R; Tomaselli GF; Kass DA; Winn MP
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1442-50. PubMed ID: 24740790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels.
    Tian D; Jacobo SM; Billing D; Rozkalne A; Gage SD; Anagnostou T; Pavenstädt H; Hsu HH; Schlondorff J; Ramos A; Greka A
    Sci Signal; 2010 Oct; 3(145):ra77. PubMed ID: 20978238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
    Kim EY; Alvarez-Baron CP; Dryer SE
    Mol Pharmacol; 2009 Mar; 75(3):466-77. PubMed ID: 19052171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes.
    Chen S; He FF; Wang H; Fang Z; Shao N; Tian XJ; Liu JS; Zhu ZH; Wang YM; Wang S; Huang K; Zhang C
    Cell Calcium; 2011 Dec; 50(6):523-9. PubMed ID: 21959089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G; Wang L; Spurney RF
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
    Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
    Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of NOD2 in mediating Ca2+ signaling: evidence from NOD2-regulated podocyte TRPC6 channels in hyperhomocysteinemia.
    Han H; Wang Y; Li X; Wang PA; Wei X; Liang W; Ding G; Yu X; Bao C; Zhang Y; Wang Z; Yi F
    Hypertension; 2013 Sep; 62(3):506-11. PubMed ID: 23856489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage.
    Semenikhina M; Fedoriuk M; Stefanenko M; Klemens CA; Cherezova A; Marshall B; Hall G; Levchenko V; Solanki AK; Lipschutz JH; Ilatovskaya DV; Staruschenko A; Palygin O
    Clin Sci (Lond); 2023 Dec; 137(24):1789-1804. PubMed ID: 38051199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase C epsilon (PLCε) induced TRPC6 activation: a common but redundant mechanism in primary podocytes.
    Kalwa H; Storch U; Demleitner J; Fiedler S; Mayer T; Kannler M; Fahlbusch M; Barth H; Smrcka A; Hildebrandt F; Gudermann T; Dietrich A
    J Cell Physiol; 2015 Jun; 230(6):1389-99. PubMed ID: 25521631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytoskeleton Rearrangements Modulate TRPC6 Channel Activity in Podocytes.
    Shalygin A; Shuyskiy LS; Bohovyk R; Palygin O; Staruschenko A; Kaznacheyeva E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.
    Dryer SE; Reiser J
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F689-701. PubMed ID: 20685822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
    Roshanravan H; Dryer SE
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
    Chiluiza D; Krishna S; Schumacher VA; Schlöndorff J
    J Biol Chem; 2013 Jun; 288(25):18407-20. PubMed ID: 23645677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.